http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5759854-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a98cb1b197f761c87cd3caf32bc247e2
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-255
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C309-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C301-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D309-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C303-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00
filingDate 1980-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_422d72587637a11f17efff95ee63fa9b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e8ad35627527244d5de6e7395a1243f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1ae6248639ce2c2d58b45fc5fc946b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1ee33a8c287018fefad8a15071f09d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b826621fff1da2042301939862c77e6
publicationDate 1982-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S5759854-A
titleOfInvention Sulfonate derivative and its preparation
abstract NEW MATERIAL:A sulfonate drivative expressed by formulaI[R is phenyl which may have a substituent group (lower alkyl, lower alkoxyl, OH, carboxyl or halogen); R2 is 3W6C cyclic alkyl, 2W5C cyclic alkyl ether, etc.; m is an integer 0W3]. n EXAMPLE: 2-oxo-4-cyclohexyl-butyl-benzenesulfonate. n USE: An antithrombotic agent, andti-inflammatory agent and immunological regulator having esterase inhibitory and chymotrypsin inhibitory actions. n PROCESS: A compound expressed by formula II is reacted with a sulfonic acid compound expressed by formula III (Y is an integer 0W2) in a solvent, e.g. petroleum ether or ligroin, at -10W+60°C to give the compound expressed by formulaI. n COPYRIGHT: (C)1982,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0117876-A1
priorityDate 1980-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588021
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35002
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1099
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427709
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236308648
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO97398
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421333438
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20435334
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20435335
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365

Total number of triples: 42.